Arvee Laboratories (India) Limited - Asset Resilience Ratio
Arvee Laboratories (India) Limited (ARVEE) has an Asset Resilience Ratio of 14.69% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Arvee Laboratories (India) Limited (ARVEE) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2025)
This chart shows how Arvee Laboratories (India) Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see total assets of Arvee Laboratories (India) Limited.
Liquid Assets Composition Over Time
This chart breaks down Arvee Laboratories (India) Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Arvee Laboratories (India) Limited (ARVEE) total liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 0% |
| Short-term Investments | Rs59.60 Million | 14.69% |
| Total Liquid Assets | Rs59.60 Million | 14.69% |
Asset Resilience Insights
- Moderate Liquidity: Arvee Laboratories (India) Limited has 14.69% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Arvee Laboratories (India) Limited Industry Peers by Asset Resilience Ratio
Compare Arvee Laboratories (India) Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
AKZO NOBEL SPONS.ADRS 1/3
F:AKUP |
Specialty Chemicals | 1.69% |
|
Cngr Advanced Material Co Ltd
SHE:300919 |
Specialty Chemicals | 0.52% |
|
Supreme Petrochem Limited
NSE:SPLPETRO |
Specialty Chemicals | 8.22% |
|
5N Plus Inc.
TO:VNP |
Specialty Chemicals | 12.56% |
|
Cofco Biochemical Anhui Co Ltd
SHE:000930 |
Specialty Chemicals | 0.01% |
|
Zhejiang Fulai New Material Co.Ltd.
SHG:605488 |
Specialty Chemicals | 1.39% |
|
Jiangxi Guotai Civilian
SHG:603977 |
Specialty Chemicals | 12.39% |
|
Suzhou Shihua New Material Technology Co Ltd
SHG:688093 |
Specialty Chemicals | 25.17% |
Annual Asset Resilience Ratio for Arvee Laboratories (India) Limited (2017–2025)
The table below shows the annual Asset Resilience Ratio data for Arvee Laboratories (India) Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 27.41% | Rs104.59 Million ≈ $1.13 Million |
Rs381.58 Million ≈ $4.13 Million |
+12.47pp |
| 2024-03-31 | 14.94% | Rs57.05 Million ≈ $617.02K |
Rs381.99 Million ≈ $4.13 Million |
+12.63pp |
| 2023-03-31 | 2.31% | Rs8.92 Million ≈ $96.44K |
Rs386.85 Million ≈ $4.18 Million |
-14.38pp |
| 2022-03-31 | 16.68% | Rs64.55 Million ≈ $698.03K |
Rs386.85 Million ≈ $4.18 Million |
-4.36pp |
| 2021-03-31 | 21.05% | Rs86.39 Million ≈ $934.30K |
Rs410.46 Million ≈ $4.44 Million |
+8.94pp |
| 2020-03-31 | 12.11% | Rs40.73 Million ≈ $440.44K |
Rs336.25 Million ≈ $3.64 Million |
-2.96pp |
| 2019-03-31 | 15.07% | Rs55.97 Million ≈ $605.34K |
Rs371.49 Million ≈ $4.02 Million |
+10.61pp |
| 2018-03-31 | 4.46% | Rs19.66 Million ≈ $212.56K |
Rs441.17 Million ≈ $4.77 Million |
+1.76pp |
| 2017-03-31 | 2.70% | Rs9.63 Million ≈ $104.17K |
Rs356.75 Million ≈ $3.86 Million |
-- |
About Arvee Laboratories (India) Limited
Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroi… Read more